Document is current
Any future updates will be listed below
-
Authors
Lu, Han
Rolls, Edmund T. https://orcid.org/0000-0003-3025-1292
Liu, Hanjia
Stein, Dan J. https://orcid.org/0000-0001-7218-7810
Sahakian, Barbara J.
Elliott, Rebecca https://orcid.org/0000-0002-7602-010X
Jia, Tianye https://orcid.org/0000-0001-5399-2953
Xie, Chao
Xiang, Shitong https://orcid.org/0000-0002-5513-4714
Wang, Nan
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
Heinz, Andreas https://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric https://orcid.org/0000-0003-4461-7646
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Orfanos, Dimitri Papadopoulos https://orcid.org/0000-0002-1242-8990
Lemaitre, Herve https://orcid.org/0000-0002-5952-076X
Poustka, Luise
Hohmann, Sarah https://orcid.org/0000-0002-5175-6698
Holz, Nathalie https://orcid.org/0000-0002-6225-9267
Fröhner, Juliane H. https://orcid.org/0000-0002-8493-6396
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi https://orcid.org/0000-0002-4600-7158
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Whelan, Robert https://orcid.org/0000-0002-2790-7281
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Feng, Jianfeng https://orcid.org/0000-0002-8890-8288
Luo, Qiang https://orcid.org/0000-0002-0426-6039
,
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 23 June 2025
First Online: 5 July 2025
Competing interests
: Dr Banaschewski served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or a speaker’s fee by Janssen, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Dr Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The remaining authors declare no competing interests.
